British Society for Haematology guidelines for the management of adult myelodysplastic syndromes-Reference-Cited by-同舟云学术

British Society for Haematology guidelines for the management of adult myelodysplastic syndromes

Published:2021-06-27 Issue:2 Volume:194 Page:267-281
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Killick Sally B.¹^ORCID,Ingram Wendy²,Culligan Dominic³,Enright Helen⁴,Kell Jonathan²,Payne Elspeth M.⁵^ORCID,Krishnamurthy Pramila⁶,Kulasekararaj Austin⁶^ORCID,Raghavan Manoj⁷,Stanworth Simon J.⁸^ORCID,Green Simone⁹,Mufti Ghulam⁶,Quek Lynn⁶,Cargo Catherine¹⁰,Jones Gail L.¹¹,Mills Juliet¹²,Sternberg Alex¹³,Wiseman Daniel H.¹⁴,Bowen David¹⁰

Affiliation:

1. University Hospitals Dorset NHS Foundation TrustThe Royal Bournemouth Hospital BournemouthUK

2. University Hospital of Wales CardiffUK

3. Aberdeen Royal Infirmary AberdeenUK

4. Tallaght University Hospital, DublinTrinity College Medical School TallaghtUK

5. University College London Cancer Institute LondonUK

6. Kings College Hospital NHS Foundation Trust LondonUK

7. University Hospitals Birmingham NHS Foundation Trust BirminghamUK

8. Oxford UniversityOxford University Hospitals NHS Trust & NHS Blood and Transplant OxfordUK

9. Hull and East Yorkshire Hospitals NHS Trust HullUK

10. St.James's Institute of OncologyLeeds Teaching Hospitals LeedsUK

11. Newcastle Hospitals NHS Foundation Trust Newcastle Upon TyneUK

12. Worcestershire Acute Hospitals NHS Trust and Birmingham NHS Foundation Trust WorcesterUK

13. Great Western Hospitals NHS Foundation Trust SwindonUK

14. The Christie NHS Foundation Trust Manchester UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17612

Reference131 articles.

1. Guidelines for the diagnosis and management of adult myelodysplastic syndromes

2. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

3. Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15

4. Time-dependent changes in mortality and transformation risk in MDS

5. Perceptions of Disease State, Treatment Outcomes, and Prognosis Among Patients with Myelodysplastic Syndromes: Results from an Internet-Based Survey

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR;Journal of Clinical Medicine;2023-10-17

2. Transfusion thresholds: the need for a patient-centered approach in hematologic disorders that require chronic transfusion therapy;Blood Research;2023-02-27

3. Stem Cell Transplant for Acute Myeloid Leukemia;Basics of Hematopoietic Stem Cell Transplant;2023

4. Management of patients with lower-risk myelodysplastic syndromes;Blood Cancer Journal;2022-12-14

5. Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation;Diagnostics;2022-10-14